In contrast, MMR germline carriers with ovarian cancer showed higher somatic variant rates in oncogenic driver genes, suggesting a heterogeneous etiology of tumorigenesis mediated by MMR germline variants in endometrial cancer. The gene discussed is MRC1; the disease is ovarian carcinoma.